Zhen Gu Selected Research

Insulin (Novolin)

1/2023	Material design for oral insulin delivery.
1/2023	Glucose-Responsive Charge-Switchable Lipid Nanoparticles for Insulin Delivery.
12/2022	Glucose-responsive microneedle patch for closed-loop dual-hormone delivery in mice and pigs.
11/2022	Microneedle Patches Loaded with Nanovesicles for Glucose Transporter-Mediated Insulin Delivery.
10/2022	Shrinking Fabrication of a Glucose-Responsive Glucagon Microneedle Patch.
1/2021	Injectable Biodegradable Polymeric Complex for Glucose-Responsive Insulin Delivery.
1/2021	Roadmap on nanomedicine.
1/2021	Developing Insulin Delivery Devices with Glucose Responsiveness.
11/2020	Dual self-regulated delivery of insulin and glucagon by a hybrid patch.
7/2020	Engineered PD-L1-Expressing Platelets Reverse New-Onset Type 1 Diabetes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhen Gu Research Topics

Disease

107	Neoplasms (Cancer) 04/2024 - 12/2009
15	Inflammation (Inflammations) 04/2024 - 05/2011
15	Infections 12/2023 - 05/2014
13	Hypoglycemia (Reactive Hypoglycemia) 12/2022 - 07/2015
10	Type 2 Diabetes Mellitus (MODY) 11/2022 - 01/2018
9	Melanoma (Melanoma, Malignant) 11/2023 - 01/2016
8	Neoplasm Metastasis (Metastasis) 07/2023 - 01/2018
8	Hypoxia (Hypoxemia) 01/2019 - 07/2015
6	Wounds and Injuries (Trauma) 04/2024 - 01/2018
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2023 - 08/2013
6	Hyperglycemia 01/2023 - 07/2015
5	Pain (Aches) 04/2024 - 05/2014
4	Hepatocellular Carcinoma (Hepatoma) 09/2023 - 01/2013
4	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 11/2014
3	Peripheral Nerve Injuries 04/2024 - 08/2023
3	Gallbladder Neoplasms (Gallbladder Cancer) 02/2024 - 01/2022
3	Breast Neoplasms (Breast Cancer) 11/2023 - 01/2017
3	Diabetes Mellitus 01/2023 - 05/2013
2	Thrombosis (Thrombus) 03/2024 - 01/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 09/2023
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2022
2	Cytokine Release Syndrome 09/2023 - 07/2020
2	Bites and Stings (Sting) 04/2023 - 12/2021
2	Colitis 02/2023 - 04/2016
2	Leukemia 03/2022 - 01/2019
2	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 10/2016
2	Alopecia (Baldness) 01/2021 - 01/2019
2	Stroke (Strokes) 01/2021 - 10/2016
2	Obesity 01/2020 - 01/2017
2	Colonic Neoplasms (Colon Cancer) 02/2019 - 11/2017

Drug/Important Bio-Agent (IBA)

24	Insulin (Novolin)FDA Link 01/2023 - 08/2013
20	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 05/2013
12	HydrogelsIBA 04/2024 - 12/2017
12	Blood Glucose (Blood Sugar)IBA 01/2023 - 08/2013
11	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2011
9	Peptides (Polypeptides)IBA 03/2024 - 04/2013
9	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2017
7	Chimeric Antigen ReceptorsIBA 04/2024 - 08/2017
6	Therapeutic UsesIBA 04/2024 - 09/2017
6	CytokinesIBA 03/2024 - 01/2016
6	EnzymesIBA 01/2023 - 08/2013
6	LigandsIBA 11/2022 - 10/2014
5	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 01/2019
5	Cancer VaccinesIBA 11/2023 - 01/2020
5	VaccinesIBA 11/2023 - 01/2018
5	Biocompatible Materials (Biomaterials)IBA 01/2022 - 08/2017
5	PolymersIBA 01/2022 - 05/2014
5	DNA (Deoxyribonucleic Acid)IBA 08/2020 - 09/2011
5	AntigensIBA 01/2020 - 05/2018
5	NanocapsulesIBA 11/2018 - 08/2011
4	NitrogenIBA 03/2024 - 12/2020
4	ProdrugsIBA 11/2023 - 01/2017
4	AcidsIBA 04/2023 - 10/2014
4	Glucagon (Glukagon)FDA Link 12/2022 - 01/2017
4	B7-H1 AntigenIBA 01/2021 - 01/2018
4	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 05/2014
3	LipidsIBA 03/2024 - 08/2014
3	Messenger RNA (mRNA)IBA 03/2024 - 11/2018
3	Neoplasm Antigens (Tumor Antigens)IBA 02/2023 - 01/2019
3	Caspase 3 (Caspase-3)IBA 11/2022 - 12/2009
3	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 07/2015
3	AntibodiesIBA 01/2021 - 01/2019
2	Analgesics (Analgesic Drugs)IBA 04/2024 - 03/2015
2	IonsIBA 11/2023 - 12/2021
2	MetalsIBA 11/2023 - 04/2023
2	BoronIBA 09/2023 - 01/2023
2	Antiviral Agents (Antivirals)IBA 07/2023 - 03/2019
2	vadimezanIBA 04/2023 - 01/2021
2	InterferonsIBA 04/2023 - 12/2021
2	Phosphates (Orthophosphate)IBA 04/2023 - 02/2019
2	OligodeoxyribonucleotidesIBA 04/2023 - 10/2016
2	Pancreatic Ribonuclease (Ribonuclease A)IBA 11/2022 - 11/2018
2	Glycoproteins (Glycoprotein)IBA 08/2022 - 01/2013
2	FibrinIBA 10/2021 - 01/2019
2	Nucleic AcidsIBA 01/2021 - 08/2020
2	fosbretabulin (combretastatin A4)IBA 11/2019 - 02/2019
2	Cisplatin (Platino)FDA LinkGeneric 02/2019 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2019 - 01/2017
2	Neuroprotective AgentsIBA 01/2019 - 10/2016
2	Drug CarriersIBA 01/2017 - 07/2015

Therapy/Procedure

70	Therapeutics 04/2024 - 07/2011
32	Immunotherapy 11/2023 - 01/2016
9	Injections 11/2023 - 05/2014
8	Drug Therapy (Chemotherapy) 01/2023 - 12/2014
3	Precision Medicine 11/2023 - 05/2015
3	Photothermal Therapy 01/2023 - 01/2018
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 01/2018
3	Intravenous Administration 01/2023 - 01/2021
2	Electroacupuncture 04/2024 - 03/2015
2	Biological Therapy 09/2023 - 01/2018
2	Cutaneous Administration 09/2023 - 01/2017
2	Radiotherapy 01/2023 - 01/2020
2	Photochemotherapy (Photodynamic Therapy) 01/2023 - 07/2021
2	Phototherapy (Light Therapy) 01/2023 - 01/2020
2	Lasers (Laser) 11/2022 - 01/2018
2	Stents 10/2022 - 06/2019
2	Electrodes (Electrode) 01/2022 - 01/2013
2	Immunomodulation 01/2022 - 03/2019
2	Topical Administration 01/2021 - 08/2020
2	Glycemic Control 04/2020 - 01/2019